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Background 
Diarrhoea is still a major contributor to deaths in young 
children living in low and middle income countries. It is 
thought that giving oral zinc supplement may speed 
recovery from diarrhoea.    
Inclusion criteria 
Studies:  
Randomized controlled trials.  
Participants: 
Children aged between one month and five years with 
acute or persistent diarrhoea, including dysentery. 
Intervention: 
Intervention: at least 5 mg per day oral zinc salt, for any 
duration. 
Control: placebo. 
Outcomes: 
Primary: duration of diarrhoea 
Adverse events: serious adverse events, adverse events 
requiring discontinuation of treatment, other adverse 
events. 
 
Results 
• Eighteen trials involving 6165 children were 
included; 12 trials had adequate allocation 
concealment. Fifteen trials were conducted in 
countries with high risk for zinc deficiency, and three 
were conducted in countries with medium risk. 
• In acute diarrhoea, zinc significantly reduced 
diarrhoea duration in children aged over six months 
(mean difference -16.67 hours, 95% confidence 
interval -31.03 to -2.31 hours; 731 children, 2 trials), 
but had no benefit in children under six months 
(1334 children, 2 trials). Zinc also reduced acute 
diarrhoea at day three (relative risk (RR) 0.69, 95% CI 
0.59 to 0.81; 1073 children, 2 trials), day five (RR 
0.55, 95% CI 0.32 to 0.95; 346 children, 2 trials), 
and day seven  (RR 0.71, 95% CI 0.52 to 0.98; 4087 
children, 7 trials), with no benefit in children under 
six months (1074 children, 1 trial). 
• Across all age groups with acute diarrhoea, vomiting 
was more common in children receiving zinc (risk 
ratio 1.71, 95% CI 1.27 to 2.30; 4727 children, 8 
trials). There were no significant differences between 
the groups in serum copper levels (2 trials). 
• In persistent diarrhoea, zinc significantly reduced 
diarrhoea duration in children aged over six months 
(MD -16.01 hours, 95% CI -26.16 to -5.86; 388 
children, 4 trials); there were no trials involving 
children aged under six months. 
• In children with persistent diarrhoea, there was no 
difference between the zinc and placebo groups in 
incidence of vomiting (505 children, 4 trials).  
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Does oral zinc reduce the duration of diarrhoea in children? 
In areas where diarrhoea is an important cause of child mortality, oral zinc reduces the 
duration of acute or persistent diarrhoea in young children over the age of six months. 
 Produced by the Effective Health Care Research Consortium (www.liv.ac.uk/evidence), Liverpool School of Tropical Medicine, supported by the 
Department for International Development UK. Evidence Update can be distributed free of charge.  
The Cochrane Database of Systematic Reviews is available from www.wiley.com, and free for eligible countries through www.healthinternetwork.org.  
Authors’ conclusions 
Implications for practice:  
In children aged six months to five years living in areas with a risk of zinc deficiency, oral zinc reduces the duration 
of acute or persistent diarrhoea. Zinc is associated with an increase in the incidence of vomiting, but this adverse 
event is outweighed by benefits on diarrhoea.  
Implications for research: 
No further trials are needed in this area, as zinc has been shown to be of clear benefit. 
Zinc vs placebo for acute diarrhoea: diarrhoea duration  
Zinc vs placebo for persistent diarrhoea: diarrhoea duration 
 
